U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C29H38N8O8.2ClH
Molecular Weight 699.583
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GUAMECYCLINE HYDROCHLORIDE

SMILES

Cl.Cl.CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]2(O)C(=O)C(C(=O)NCN5CCN(CC5)C(=N)NC(N)=N)=C1O

InChI

InChIKey=SNUNMHCZVZIEMV-KGHBUBBXSA-N
InChI=1S/C29H38N8O8.2ClH/c1-28(44)13-5-4-6-16(38)17(13)21(39)18-14(28)11-15-20(35(2)3)22(40)19(24(42)29(15,45)23(18)41)25(43)33-12-36-7-9-37(10-8-36)27(32)34-26(30)31;;/h4-6,14-15,20,38,40-41,44-45H,7-12H2,1-3H3,(H,33,43)(H5,30,31,32,34);2*1H/t14-,15-,20-,28+,29-;;/m0../s1

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C29H38N8O8
Molecular Weight 626.6608
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Guamecycline, a tetracycline derivative was studied in patients with broncho-pulmonary diseases and for the treatment of acute pneumopathies. However, information about the current use of this compound is not available.

Approval Year

PubMed

PubMed

TitleDatePubMed
[Guamecycline in the treatment of acute pneumopathies. Clinical research and comparison with other tetracyclines].
1972-11-21
Guamecycline in bronchial infections due to Diplococcus pneumoniae.
1972-01-01
[Effects of aerosol administration of guamecycline in patients with broncho-pulmonary diseases].
1971-01-01
[Inhibiting effects of guamecycline and of tetracycline hydrochloride on antibody-producing cells of the spleen and lymph nodes].
1971-01-01
Guamecycline and the bronchopulmonary system. Measurement of antibiotic levels in bronchial secretion.
1969-10
Preliminary report: electron microscopical appearance of human bronchial epithelium after long-term treatment with guamecycline by aerosol route.
1969
Patents

Sample Use Guides

Unknown
Route of Administration: Respiratory
Substance Class Chemical
Created
by admin
on Mon Mar 31 22:10:27 GMT 2025
Edited
by admin
on Mon Mar 31 22:10:27 GMT 2025
Record UNII
DL609MM5I8
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GUAMECYCLINE DIHYDROCHLORIDE
MI  
Preferred Name English
GUAMECYCLINE HYDROCHLORIDE
WHO-DD  
Common Name English
2-NAPHTHACENECARBOXAMIDE, N-((4-(((AMINOIMINOMETHYL)AMINO)IMINOMETHYL)-1-PIPERAZINYL)METHYL)-4-(DIMETHYLAMINO)-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,6,10,12,12A-PENTAHYDROXY-6-METHYL-1,11-DIOXO-, HYDROCHLORIDE (1:2), (4S,4AS,5AS,6S,12AS)-
Systematic Name English
TERRATREX
Brand Name English
GUAMECYCLINE HCL
Common Name English
GUAMECYCLINE DIHYDROCHLORIDE [MI]
Common Name English
NSC-118695
Code English
XANTHOMYCIN A, HYDROCHLORIDE
Common Name English
XANTHOCYCLINE
Common Name English
Guamecycline hydrochloride [WHO-DD]
Common Name English
Code System Code Type Description
NSC
118695
Created by admin on Mon Mar 31 22:10:27 GMT 2025 , Edited by admin on Mon Mar 31 22:10:27 GMT 2025
PRIMARY
CAS
1401-85-0
Created by admin on Mon Mar 31 22:10:27 GMT 2025 , Edited by admin on Mon Mar 31 22:10:27 GMT 2025
SUPERSEDED
SMS_ID
100000086694
Created by admin on Mon Mar 31 22:10:27 GMT 2025 , Edited by admin on Mon Mar 31 22:10:27 GMT 2025
PRIMARY
CAS
11119-59-8
Created by admin on Mon Mar 31 22:10:27 GMT 2025 , Edited by admin on Mon Mar 31 22:10:27 GMT 2025
SUPERSEDED
MERCK INDEX
m1182
Created by admin on Mon Mar 31 22:10:27 GMT 2025 , Edited by admin on Mon Mar 31 22:10:27 GMT 2025
PRIMARY Merck Index
EVMPD
SUB02422MIG
Created by admin on Mon Mar 31 22:10:27 GMT 2025 , Edited by admin on Mon Mar 31 22:10:27 GMT 2025
PRIMARY
CAS
13040-98-7
Created by admin on Mon Mar 31 22:10:27 GMT 2025 , Edited by admin on Mon Mar 31 22:10:27 GMT 2025
PRIMARY
EPA CompTox
DTXSID80926719
Created by admin on Mon Mar 31 22:10:27 GMT 2025 , Edited by admin on Mon Mar 31 22:10:27 GMT 2025
PRIMARY
CAS
51025-86-6
Created by admin on Mon Mar 31 22:10:27 GMT 2025 , Edited by admin on Mon Mar 31 22:10:27 GMT 2025
SUPERSEDED
CAS
19115-46-9
Created by admin on Mon Mar 31 22:10:27 GMT 2025 , Edited by admin on Mon Mar 31 22:10:27 GMT 2025
SUPERSEDED
FDA UNII
DL609MM5I8
Created by admin on Mon Mar 31 22:10:27 GMT 2025 , Edited by admin on Mon Mar 31 22:10:27 GMT 2025
PRIMARY
ECHA (EC/EINECS)
235-913-5
Created by admin on Mon Mar 31 22:10:27 GMT 2025 , Edited by admin on Mon Mar 31 22:10:27 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY